| Element List | Explanation |
|---|---|
| Introduction | The Board of Directors of Almujtama Alraida Medical Co. is pleased to invite the Company's valued shareholders to participate and vote in the Ordinary General Assembly Meeting (First Meeting), which is scheduled to be held, God willing, at 8:30 p.m. on Monday, 29 June 2026, corresponding to 14/01/1448 AH, through modern technology means. |
| City and Location of the General Assembly's Meeting | Company headquarters - Jeddah - Al-Muhammadiyah district (Via modern technology means) |
| Hyperlink of the Meeting Location | Click Here |
| Date of the General Assembly's Meeting | 2026-06-29 Corresponding to 1448-01-14 |
| Time of the General Assembly’s Meeting | 20:30 |
| Methodology of Convening the General Assembly’s Meeting | Via modern technology means |
| Attendance Eligibility, Registration Eligibility, and Voting End | The right to attend the General Assembly Meeting shall be granted to shareholders registered in the issuer’s shareholders register at the Depository Center at the close of trading on the day preceding the General Assembly Meeting, in accordance with the applicable laws and regulations. Eligibility to register attendance for the General Assembly Meeting shall end at the time the meeting commences, and the right of attendees to vote on the agenda items shall expire once the vote-counting committee has completed the counting of votes. |
| Quorum for Convening the General Assembly's Meeting | For this General Assembly Meeting to be validly convened, shareholders representing at least one-quarter of the Company’s voting shares must be present. If the required quorum for the first meeting is not met, a second meeting shall be held one hour after the end of the period specified for the first meeting. The second meeting shall be valid regardless of the number of voting shares represented therein, pursuant to Article (28) of the Company’s Articles of Association. |
| General Assembly Meeting Agenda | 1. To review and discuss the Board of Directors’ Report for the fiscal year ended 31 December 2025. 2. To review and discuss the financial statements for the fiscal year ended 31 December 2025. 3. To vote on the Company’s External Auditor’s Report for the fiscal year ended 31 December 2025 after discussing it. 4. To vote on the payment of remuneration to the members of the Board of Directors amounting to SAR 906,575 for the fiscal year ended 31 December 2025. 5. To vote on discharging the members of the Board of Directors from liability for the fiscal year ended 31 December 2025. 6. To vote on appointing the Company’s external auditor from among the candidates recommended by the Audit Committee to examine, review and audit the semi-annual and annual financial statements for the fiscal year ending 31 December 2026, submit the Zakat return for 2026, and determine the auditor’s fees. 7. To vote on the Board of Directors’ recommendation to distribute cash dividends amounting to SAR 2,375,000 to shareholders for the fiscal year 2025, at SAR 0.25 per share, representing 2.5% of the Company’s capital of SAR 95,000,000. Eligibility shall be for shareholders holding shares at the close of trading on the date of the General Assembly Meeting and registered in the Company’s shareholders register maintained by the Securities Depository Center Company (Edaa) at the end of the second trading day following the date of the General Assembly Meeting. Dividend distribution shall commence on 19 July 2026. 8. To vote on authorizing the Board of Directors to distribute interim dividends to shareholders on a semi-annual or quarterly basis for the fiscal year 2026 and to determine the distribution and eligibility dates. 9. To vote on the transactions and contracts executed during 2025 between the Company and Mr. Omar Yousef Khojah, in which the Chairman of the Board, Mr. Omar Yousef Khojah, has a direct interest, while the Vice Chairman, Mr. Yousef Omar Khojah, and Board Member Pharmacist Abdulaziz Omar Khojah have indirect interests. The transaction relates to a lease agreement for a branch located in Al Shiraa District, Jeddah, with an annual rent of SAR 160,000 excluding 15% VAT, for a one-year term ending on 06 September 2026. The value of transactions during fiscal year 2025 amounted to SAR 160,000 excluding VAT. Approval is requested to renew the lease for one additional year until 06 September 2027. All terms and conditions of the agreement were negotiated on an arm’s-length basis without granting any preferential treatment or special benefits to any party. 10. To vote on the transactions and contracts entered into between the Company and Mr. Omar Yousef Khojah, in which the Chairman of the Board, Mr. Omar Yousef Khojah, has a direct interest, while the Vice Chairman, Mr. Yousef Omar Khojah, and Board Member Pharmacist Abdulaziz Omar Khojah have indirect interests. The transaction relates to a lease agreement for a branch located in Al Sanabel District, Jeddah, for a period of ten (10) years commencing on 01 April 2023, with a total lease value of SAR 5,500,000 excluding 15% VAT. The value of transactions during fiscal year 2025 amounted to SAR 550,000 excluding VAT. Approval is requested to continue the contract during fiscal year 2026. This contract was concluded without any preferential terms or special advantages. 11. To vote on the transactions and contracts entered into between the Company and Mr. Omar Yousef Khojah, in which the Chairman of the Board, Mr. Omar Yousef Khojah, has a direct interest, while the Vice Chairman, Mr. Yousef Omar Khojah, and Board Member Pharmacist Abdulaziz Omar Khojah have indirect interests. The transaction relates to a lease agreement for a branch located in Al Rahili District, Jeddah, for a period of nine (9) years and eleven (11) months commencing on 01 May 2023, with a total lease value of SAR 3,966,667 excluding 15% VAT. The value of transactions during fiscal year 2025 amounted to SAR 400,000 excluding VAT. Approval is requested to continue the contract during fiscal year 2026. This contract was concluded without any preferential terms or special advantages. 12. To vote on the transactions and contracts entered into between the Company and Mr. Omar Yousef Khojah, in which the Chairman of the Board, Mr. Omar Yousef Khojah, has a direct interest, while the Vice Chairman, Mr. Yousef Omar Khojah, and Board Member Pharmacist Abdulaziz Omar Khojah have indirect interests. The transaction relates to a lease agreement for a branch located in Al Marwah District, Jeddah, for a period of ten (10) years commencing on 01 July 2024, with a total lease value of SAR 4,200,000 excluding 15% VAT. The value of transactions during fiscal year 2025 amounted to SAR 420,000 excluding VAT. Approval is requested to continue the contract during fiscal year 2026. This contract was concluded without any preferential terms or special advantages. 13. To vote on the transactions and contracts entered into between the Company and Bright Screens Company (a single-owner limited liability company owned by Mr. Mohammed Omar Khojah), in which the Chairman of the Board, Mr. Omar Yousef Khojah, the Vice Chairman, Mr. Yousef Omar Khojah, and Board Member Pharmacist Abdulaziz Omar Khojah have indirect interests. The transaction relates to the supply and installation of advertising screens under a contract with a total value of SAR 1,537,200 excluding 15% VAT. The value of transactions during fiscal year 2025 amounted to SAR 699,478 excluding VAT. Approval is requested to continue the supply arrangement during fiscal year 2026. This contract was concluded without any preferential terms or special advantages. |
| Proxy Form | Proxy Form |
| The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right | Shareholders attending the General Assembly Meeting shall have the right to discuss the items on the meeting agenda, direct questions, and vote on such items through the Tadawulaty platform: www.tadawulaty.com.sa |
| Details of the electronic voting on the Assembly’s agenda | Shareholders registered with Tadawulaty Services will be able to vote remotely on the agenda items of the General Assembly Meeting through the electronic voting service. Electronic voting will commence at 1:00 a.m. on Thursday, 25 June 2026, corresponding to 10/01/1448 AH, and will continue until the end of the Ordinary General Assembly Meeting. Registration and voting through Tadawulaty Services will be available free of charge to all shareholders via the following link: www.tadawulaty.com.sa |
| Method of Communication in Case of Any Enquiries | Should you have any inquiries regarding the agenda items of the General Assembly Meeting, please contact the Shareholder Relations Department at telephone number 920008144, extension 710, or via email at secretary@almujtama.com.sa. |
| Attached Documents | Attached Documents Attached Documents Attached Documents Attached Documents |